Solexa said it will choose the DNA from a set of anonymous samples recently used in the International Haplotype Mapping Project. The company said the project will enable researchers to compare its results with other publicly available data.
"In sequencing a human genome, our aim is to demonstrate the performance of the Solexa Genome Analysis System," David Bentley, chief scientist of Solexa, said in a statement.
Solexa said it will release sequence data at "regular intervals" in 2006 "so that researchers can objectively assess the output of the Solexa Genome Analysis System in comparison with previously validated, high-quality genetic data already in the public domain."
Solexa disclosed its plans to sequence the human genome on the day it launched its Genome Analysis System. The tool comprises the Solexa 1G Genetic Analyzer, the Solexa Cluster Station and associated reagents, consumables, and software, and is designed to generate more than 1 billion bases of sequence per run.
CEO John West reiterated earlier comments that the company "expect[s]" to begin accepting orders and ship initial production units during the second quarter of next year.